Beneficial effect of a loading dose of 600mg of clopidogrel on platelet parameters in patients admitted for acute coronary syndrome;Bénéfice d'une dose de charge de 600 mg de clopidogrel sur les paramètres plaquettaires chez les patients admis pour syndrome coronaire aigu

Archives des Maladies du Coeur et des Vaisseaux

Volumn 99, Issue 10, 2006, Pages 889-893

  Cuisset, Thomas ^a   Frere C ^a   Quilici, J ^a   Morange, P E ^a   Nait Saidi, L ^a   Carvajal, J ^a   Lambert, M ^a   Mouret, J P ^a   Alessi, M C ^a   Bonnet, J L ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOPIDOGREL; PADGEM PROTEIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; LOADING DRUG DOSE; MALE; THERAPY EFFECT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME;

ACUTE DISEASE; ANGINA, UNSTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; SYNDROME; TICLOPIDINE;

EID: 33846829716     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Yusuf S, Zhao F, Mehta SR, et al. Clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
2. Mehta SR, Yusuf S, Peters RJ, et al. Clopidogrel in unstable angina to prevent recurrent events trial (CURE) investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33.
3. Steinhubl SR, Berger PB, Mann JT 3rd, et al. CREDO Investigators. Clopidogrel for the reduction of events during observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20.
4. Kastrati A, Von Beckerath N, Joost A, et al. Loading with 600 mg clopidogrel in patients witn coronary artery disease with and without chronic clopidogrel therapy. Circulation 2004;110:1916-9.
5. Patti G, Colonna G, Pasceri V, et al. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention. Results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study. Circulation 2005;111:2099-106.
6. Cuisset T, Frere C, Quilici J, et al. High Post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost 2006.
7. Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-13.
8. Muller I, Besta F, Schulz C, et al. Prevalence of clopidogrel nonresponders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost 2003;89:783-7.
9. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stentinq. Thromb Res 2005;115:101-8
10. Serebruany VL, Steinhubl SR, Berger PB, et al. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005;45(2):246-51.
11. Aleil B, Gachet C. The interindividual variability of the response to clopidogrel. Arch Mal Cœur 2005;98:216-25.
12. Samara WM, Bliden KP, Tantry US, Gurbel et al. The difference between clopidogrel responsiveness and posttreatment platelet reactivity. Thromb Res 2005;115:89-94.
13. Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004;109:3171-5.